Sweden Platelet Rich Plasma (prp) Market Size & Outlook
Related Markets
Sweden platelet rich plasma (prp) market highlights
- The Sweden platelet rich plasma (prp) market generated a revenue of USD 2.4 million in 2023 and is expected to reach USD 5.6 million by 2030.
- The Sweden market is expected to grow at a CAGR of 13% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2023 | USD 2.4 million |
| Market revenue in 2030 | USD 5.6 million |
| Growth rate | 13% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Sweden accounted for 0.4% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 123.0 million by 2030.
Pure prp was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the Sweden platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
The Sweden PRP market is witnessing significant growth, driven by the rising prevalence of musculoskeletal conditions, including degenerative joint disease and osteoarthritis. PRP is considered an orthobiologic treatment and utilizes natural substances found in the human body to accelerate the healing process.
Swedish physicians often offer PRP therapy as an alternative when conventional treatments have proven ineffective for patients. The increasing awareness of PRP's effectiveness in treating musculoskeletal diseases, coupled with its minimally invasive nature and potential for improved patient outcomes, has contributed to its growing popularity in Sweden.
As a result, the market for PRP therapy for musculoskeletal conditions is expected to continue expanding, with a focus on providing innovative and efficient solutions for patients dealing with these health issues.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Sweden platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
Sweden Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
